華虹半導體領漲芯片股,報道稱華爲和中芯國際已獲上千億美元的美國技術出口許可
芯片股早盤全線走高,截至發稿,晶門半導體漲6.58%,報0.81港元;華虹半導體漲4.86%,報42.05港元;中芯國際漲4.07%,報23港元;上海復旦漲2.17%,報21.2港元。
消息面上,據媒體報道,美國國會週四聽證會透出信息,去年11月至今年4月間,華爲和中芯國際獲得合計價值上千億美元的美國技術出口許可。據文件顯示,美國同意供應商銷貨給華爲的出口許可有113份,價值610億美元;此外,還有188份價值近420億美元的出口許可授予中芯國際供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.